AI assistant
4DMEDICAL LIMITED — Share Issue/Capital Change 2021
Jun 27, 2021
64259_rns_2021-06-27_62a657fe-6a15-41c7-8602-a23cda5b10c0.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
4DMEDICAL LIMITED
Date of this announcement
Monday June 28, 2021
The +securities the subject of this notification are:
+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends
Total number of +securities to be issued/transferred
| Total number of | |||
|---|---|---|---|
| ASX +security | +securities to be | ||
| code | Security description | issued/transferred | Issue date |
| New class - code | OPTION EXPIRING 25-DEC-2024 EX $2.33 | 66,476 | 25/06/2021 |
| to be confirmed | |||
| New class - code | OPTION EXPIRING 25-JUN-2025 EX $1.30 | 1,346,155 | 25/06/2021 |
| to be confirmed |
Refer to next page for full details of the announcement
Notification of Issue, Conversion or Payment up of Unquoted E it S iti
1 / 8
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 1 - Entity and announcement details
1.1 Name of entity
4DMEDICAL LIMITED
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 Registered number type
ACN
Registration number
161684831
1.3 ASX issuer code
4DX
1.4 The announcement is
==> picture [8 x 8] intentionally omitted <==
New announcement
1.5 Date of this announcement
28/6/2021
Notification of Issue, Conversion or Payment up of Unquoted E it S iti
2 / 8
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 2 - Issue details
2.1 The +securities the subject of this notification are:
+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends
2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:
==> picture [8 x 8] intentionally omitted <==
does not have an existing ASX security code ("new class")
Notification of Issue, Conversion or Payment up of Unquoted E it S iti
3 / 8
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B
==> picture [538 x 554] intentionally omitted <==
----- Start of picture text -----
New +securities issued under an +employee incentive scheme
ASX +security code +Security description
New class - code to be confirmed OPTION EXPIRING 25-DEC-2024 EX $2.33
+Security type ISIN code
Options
Date the +securities the subject of this notification were issued
25/6/2021
Will all the +securities issued in this class rank equally in all respects from their issue date?
Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate?
No
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under
listing rule 6.1?
Yes
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being
issued.
A general summary of the plan is set out in the company¿s IPO prospectus which is available at the following URL:
https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264279.pdf
The Long Term Incentive Plan Rules are available at the following URL:
https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264299.pdf
Options Details
+Security currency Exercise price Expiry date
AUD - Australian Dollar AUD 2.33000000 25/12/2024
Details of the existing class of +security that will be issued upon exercise or conversion of this new class of
company option
Other
Description
4DX fully paid ordinary shares
----- End of picture text -----
Notification of Issue, Conversion or Payment up of Unquoted E it S iti
4 / 8
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms
The Long Term Incentive Plan Rules are available at the following URL: https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264299.pdf
Any other information the entity wishes to provide about the +securities the subject of this notification
The grant of options has been made on the following key terms:
¿ The only vesting condition is that the holder of the options must remain employed by 4DMedical (or one of its related entities) for a period of two and a half years from the grant date in order for those options to vest and become exercisable.
¿ Once vested those options remain exercisable by the holder for a period up to 12 months, after which time any unvested or unexercised options will then automatically lapse. ¿ The options are otherwise subject to the rules of the Long Term Incentive Plan.
Issue details
Number of +securities
66,476
New +securities issued under an +employee incentive scheme
==> picture [495 x 32] intentionally omitted <==
----- Start of picture text -----
ASX +security code +Security description
New class - code to be confirmed OPTION EXPIRING 25-JUN-2025 EX $1.30
----- End of picture text -----
| +Security type | ISIN code |
|---|---|
| Options | |
| Date the +securities the subject of this notification were issued | |
| 25/6/2021 |
Will all the +securities issued in this class rank equally in all respects from their issue date? Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate? No
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1? Yes
Notification of Issue, Conversion or Payment up of Unquoted E it S iti
5 / 8
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued.
A general summary of the plan is set out in the company¿s IPO prospectus which is available at the following URL: https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264279.pdf The Long Term Incentive Plan Rules are available at the following URL: https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264299.pdf
Options Details
+Security currency
AUD - Australian Dollar
Exercise price Expiry date AUD 1.30000000 25/6/2025
Details of the existing class of +security that will be issued upon exercise or conversion of this new class of company option
Other
Description
4DX fully paid ordinary shares
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms
The Long Term Incentive Plan Rules are available at the following URL: https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264299.pdf
Any other information the entity wishes to provide about the +securities the subject of this notification
The grant of options has been made on the following key terms:
¿ The only vesting condition is that the holders of the options must remain employed by 4DMedical (or one of its related entities) for a period of three years from the grant date in order for those options to vest and become exercisable. ¿ Once vested those options remain exercisable by the holders for a period up to 12 months, after which time any unvested or unexercised options will then automatically lapse.
¿ The options are otherwise subject to the rules of the Long Term Incentive Plan.
Issue details
Number of +securities
1,346,155
Notification of Issue, Conversion or Payment up of Unquoted E it S iti
6 / 8
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 4 - +Securities on issue
Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:
(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)
4.1 Quoted +Securities (Total number of each +class of +securities quoted)
| Total number of | |
|---|---|
| ASX +security code and description | +securities on issue |
| 4DX : ORDINARY FULLY PAID | 207,167,466 |
| 4.2 Unquoted +Securities (Total number of each +class of +securities issued but not | quoted on ASX) |
| Total number of | |
| ASX +security code and description | +securities on issue |
| 4DXAL : ORDINARY FULLY PAID RESTRICTED | 1,736,255 |
| 4DXAA : ORDINARY FULLY PAID RESTRICTED | 85,536,074 |
| 4DXAG : OPTION EXPIRING VAR DATES RESTRICTED EX VAR PRICES | 12,770,998 |
| 4DXAH : OPTION EXPIRING 24-OCT-2022 EX 71C | 2,256,775 |
| 4DXAI : OPTION EXPIRING 31-DEC-2024 RESTRICTED EX 40C | 2,000,000 |
| 4DXAJ : OPTION EXPIRING 15-MAR-2027 EX $1.20 | 2,133,333 |
| 4DXAK : OPTION EXPIRING 07-AUG-2024 EX 73C | 1,441,012 |
| 4DXAM : OPTION EXPIRING 15-MAR-2025 EX $2.33 | 14,367 |
| New class - code to be confirmed : OPTION EXPIRING 25-DEC-2024 EX $2.33 | 66,476 |
| New class - code to be confirmed : OPTION EXPIRING 25-JUN-2025 EX $1.30 | 1,346,155 |
4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)
Notification of Issue, Conversion or Payment up of Unquoted E it S iti
7 / 8
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 5 - Other Listing Rule requirements
5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1? Yes
5.1a Select the number of the applicable exception in Listing Rule 7.2
13
Notification of Issue, Conversion or Payment up of Unquoted E it S iti
8 / 8